Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2020 Earnings Conference Call May 7, 2020 5:00 PM ET Company Participants Dan Dischner - VP of Corporate Communications Tony Marrs - VP of Clinical Research William Peters - CFO, Treasurer & Senior VP of Finance Conference Call Participants Tim Chiang - Northland Securities Gary Nachman - BMO Capital Markets Lucas Lee - Raymond James David Steinberg - Jefferies Operator [Abrupt Start] All statements on this conference call that are not historical are forward- ...

Table of Contents | --- | |-------------------------------------------------------------------------------------| | | | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | | FORM 10-Q | ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2020 or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36509 | --- | ...

| --- | --- | |-------|---------------------------------------------------------------------------------| | | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | | | FORM 10-K | ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ Commission File Number 001-36509 AMPHASTAR ...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2019 Results Conference Call March 12, 2020 5:00 PM ET Company Participants Jason Shandell - President Bill Peters - Chief Financial Officer Conference Call Participants Rafay Sardar - BMO Capital Markets Lucas Lee - Raymond James David Steinberg - Jefferies David Amsellem - Piper Sandler Tian Sun - Needham & Company Operator Ladies and gentlemen, thank for standing by, and welcome to the Amphastar fourth quarter earnings call. [Operator Instructions] I'll no ...

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2019 Earnings Conference Call November 7, 2019 5:00 PM ET Company Participants Jason Shandell - President Bill Peters - CFO Conference Call Participants David Amsellem - Piper Jaffray Gary Nachman - BMO Capital Markets David Steinberg - Jefferies Sameer Kandola - Wells Fargo Securities Operator [Call starts abruptly] This conference call may contain forward-looking statements, including statements relating to Amphastar Pharmaceuticals. These statements are no ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019 or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36509 AMPHASTAR PHARMACEUTICALS, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other ...